A Clinical Trial of IntensiVE DIALYSIS

ANZ clinical trials registry number: NCT00649298

Principal Investigator: Professor Vlado Perkovic, the George Institute for Global Health, Sydney, NSW

ACTIVE DIALYSIS is a prospective, randomised trial designed to provide definite evidence on the benefits and costs of extending weekly haemodialysis hours beyond current standards. Led by a steering committee of nephrologists and endorsed by the AKTN, the study is coordinated by the Renal Division at the George Institute for Global Health. The trial is funded by a National Health and Medical Research Council (NHMRC) Project Grant with a supplementary unrestricted grant from Baxter. Participants are being enrolled from both the home haemodialysis and in-centre settings and are randomised to standard or extended weekly hours of haemodialysis for 12 months.

This trial is endorsed by the Australasian Kidney Trials Network, and is being fully coordinated through the George Institute for Global Health.